Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
allogeneic stem cells (1 trial)
autologous hematopoietic stem cells (1 trial)
autologous mononuclear stem cell (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
Multiple Myeloma (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Trials (1 total)
Trial APIs (4 total)